Food Standards (Application A1167 – Lactase from Bacillus subtilis as a PA (Enzyme)) Variation

Administered by Department of Health, Disability and Ageing

Legislation au F2019L00712 Not in force Legislative Instrument

Legislation content

Explanatory Statement

1. Authority

 

Section 13 of the Food Standards Australia New Zealand Act 1991 (the FSANZ Act) provides that the functions of Food Standards Australia New Zealand (the Authority) include the development of standards and variations of standards for inclusion in the Australia New Zealand Food Standards Code (the Code).

 

Division 1 of Part 3 of the FSANZ Act specifies that the Authority may accept applications for the development or variation of food regulatory measures, including standards. This Division also stipulates the procedure for considering an application for the development or variation of food regulatory measures.

 

The Authority accepted application A1167 which seeks to permit the use of a β-galactosidase enzyme from Bacillus subtilis as a processing aid for use in dairy processing. The Authority considered the application in accordance with Division 1 of Part 3 and has approved a draft variation to the Code.

 

Following consideration by the Australia and New Zealand Ministerial Forum on Food Regulation, section 92 of the FSANZ Act stipulates that the Authority must publish a notice about the standard or draft variation of a standard.

 

Section 94 of the FSANZ Act specifies that a standard, or a variation of a standard, in relation to which a notice is published under section 92 is a legislative instrument, but is not subject to parliamentary disallowance or sunsetting under the Legislation Act 2003

 

2. Purpose

 

The Authority has approved a draft variation to permit the enzyme β-galactosidase sourced from Bacillus subtilis containing the gene for β-galactosidase from Bifidobacterium bifidum, to be used as a processing aid for use in the production of low lactose and lactose free dairy products and galacto-oligosaccharides at GMP. This permission requires an addition to the table to subsection S18—9(3) in Schedule 18.

 

3. Documents incorporated by reference

 

The variations to food regulatory measures do not incorporate any documents by reference.

 

Existing provisions of the Code incorporate a document by reference that will prescribe identity and purity specifications for the processing aid to be permitted by the draft variation. Section 1.1.1—15 of the Code requires substances used as processing aids to comply with any relevant identity and purity specifications listed in Schedule 3 of the Code. Section S3—2 of Schedule 3 incorporates by reference the specifications listed in the Joint FAO/WHO Expert Committee on Food Additives (JECFA) Compendium of Food Additive Specifications (FAO/WHO 2016) and the United States Pharmacopeial Convention (2016) Food Chemicals Codex (10th edition). These include specifications for enzyme preparations used in food processing.

 

4. Consultation

 

In accordance with the procedure in Division 1 of Part 3 of the FSANZ Act, the Authority’s consideration of application A1167 included one round of public consultation following assessment and the preparation of a draft variation and associated assessment summary. Submissions were called for on 22 November 2018 for an eight-week consultation period.

 

A Regulation Impact Statement was not required because the proposed variations to Schedule 18 are likely to have a minor impact on business and individuals.

 

5. Statement of compatibility with human rights

 

This instrument is exempt from the requirements for a statement of compatibility with human rights as it is a non-disallowable instrument under section 94 of the FSANZ Act.

 

6. Variation

 

The approved draft variation inserts a new entry into the table to subsection S18—9(3) in Schedule 18.

 

The new entry will permit the use of the enzyme, β-galactosidase (EC 3.2.1.23) sourced from Bacillus subtilis containing the gene for β-galactosidase from Bifidobacterium bifidum, as a processing aid in food for a specific technological purpose, with the condition that the maximum permitted level or amount that may be used must be consistent with good manufacturing practice. The technological purpose is for use in the production low lactose and lactose free dairy products and galacto-oligosaccharides.

 

 

Overview

The Food Standards Australia New Zealand Act 1991 (FSANZ Act) serves to empower Food Standards Australia New Zealand (FSANZ) in developing and managing food standards across Australia and New Zealand. This Act was enacted to address the need for consistent and scientifically sound food standards, ensuring public health protection and facilitating trade. The Act outlines procedures for the development and variation of food standards, including mechanisms for public consultation and ministerial oversight. One of the key objectives of the FSANZ Act is to enable the FSANZ Authority to accept and consider applications for the development or variation of food regulatory measures, including standards. Following the consideration and approval of an application, such as application A1167, which seeks to permit the use of specific enzymes as processing aids in dairy processing, the Authority must publish a notice about the standard or draft variation of a standard, as mandated by section 92 of the FSANZ Act. The approved draft variation in this case pertains to the use of β-galactosidase enzyme sourced from Bacillus subtilis as a processing aid in the production of low lactose and lactose-free dairy products, subject to good manufacturing practices.

Scope and Application

The Act applies to Food Standards Australia New Zealand (the Authority) as it pertains to the development and variation of food regulatory measures, including standards, as per section 13 of the Food Standards Australia New Zealand Act 1991. The Authority's approval of the draft variation to permit the use of a β-galactosidase enzyme from Bacillus subtilis as a processing aid in dairy processing is a specific application of this legislative function. The geographic scope of this Act is national, affecting both Australia and New Zealand as outlined in the Australia New Zealand Food Standards Code. The application of this legislation is not subject to parliamentary disallowance or sunsetting under the Legislation Act 2003, as specified in section 94 of the FSANZ Act. The draft variation, once finalised, will be incorporated into the Code and will apply to entities involved in dairy processing within the jurisdiction of both Australia and New Zealand.

Key Provisions

The key operative sections of the legislation, as outlined in the explanatory statement, involve the approval of a draft variation to the Australia New Zealand Food Standards Code (the Code) (section 92 and 94 of the FSANZ Act). Specifically, the legislation permits the use of a β-galactosidase enzyme sourced from Bacillus subtilis, containing the gene for β-galactosidase from Bifidobacterium bifidum, as a processing aid in the production of low lactose and lactose-free dairy products and galacto-oligosaccharides (subsection S18—9(3) in Schedule 18). The Authority has accepted and considered an application for this variation in accordance with the FSANZ Act (section 13), and following consideration by the Australia and New Zealand Ministerial Forum on Food Regulation, the Authority must publish a notice regarding the draft variation (section 92). This variation is a legislative instrument and is not subject to parliamentary disallowance or sunsetting (section 94). The obligations and requirements imposed by this Act on the parties or entities it governs include the acceptance and consideration of applications for variations to food regulatory measures, including standards, in accordance with the FSANZ Act (section 13). Additionally, the Authority must publish a notice about the standard or draft variation of a standard (section 92). The Authority has also included one round of public consultation following the assessment and preparation of a draft variation and associated assessment summary (Division 1 of Part 3 of the FSANZ Act). Existing provisions of the Code require substances used as processing aids to comply with relevant identity and purity specifications listed in Schedule 3 of the Code, which incorporates by reference the specifications listed in the Joint FAO/WHO Expert Committee on Food Additives (JECFA) Compendium of Food Additive Specifications (FAO/WHO 2016) and the United States Pharmacopeial Convention (2016) Food Chemicals Codex (10th edition) (section 1.1.1—15 and S3—2 of Schedule 3). There are no specific offences, penalties, or civil/criminal consequences for breach outlined in the explanatory statement. However, the draft variation is a legislative instrument and is not subject to parliamentary disallowance or sunsetting under the Legislation Act 2003 (section 94). This means that the variation is legally binding and must be adhered to by relevant parties or entities. Failure to comply with the approved variation and the requirements of the FSANZ Act may result in regulatory action or other consequences as determined by the relevant authorities.

Legal classification tags

Area of Law
Food Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Licensing & Registration

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.